Publizoom

NOVO NORDISK PHARMA, S.A.

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
12
Amount won alone
€9,028,641 excl. VAT
Shared contracts
1 (multi-supplier framework agreements)
Period
13 July 2026 – 19 October 2026

Its main clients

Where and what

Supplies · 12

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
2 February 2027
re-tender around October 2026		 Expediente 2204/2025, nº siglo 578/2025, cca +6.i+e9q8j contr bam 2026 203195, con la empresa novo nordisk pharma, s.a
Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar framework agreement		 NOVO NORDISK PHARMA, S.A
1 bid received		 €20,894
11 June 2027
re-tender around December 2026		 Suministro del medicamento exclusivo: Eptacog alfa (NOVOSEVEN).
Servicio Madrileño de Salud - Hospital Universitario La Paz 		NOVO NORDISK PHARMA, S.A.
1 bid received		 €1,498,940
22 July 2027
re-tender around January 2027		 Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de SOMATROPINA PARA EL SÍNDROME DE NOONAN, para GESTIÓ PIUS HOSPITAL DE VALLS, SAM
Gestió Pius Hospital de Valls, SAM framework agreement		 NOVO NORDISK PHARMA, S.A.
1 bid received		 €311,850
18 May 2028
re-tender around November 2027		 Cbam 578/2025 novo nordisk/01
SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA 		NOVO NORDISK PHARMA, S.A.
1 bid received		 €2,884,615
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Esperoct (B02BD02), NovoEight (B02BD02) und Alhemo (B02BX10) zur Behandlung der Hämophilie
AOK Sachsen - Anhalt 		Novo Nordisk Pharma GmbH
1 bid received		 €1
31 August 2028
re-tender around March 2028		 Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu dem Wirkstoff Concizumab (Alhemo®)
AOK Baden-Württemberg framework agreement		 Novo Nordisk Pharma GmbH
1 bid received		 €216,000
31 August 2028
re-tender around March 2028		 Vereinbarung gemäß § 130c Abs. 1 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit den Wirkstoffen Turoctocog alfa (NovoEight®) und Turoctocog alfa pegol (Esperoct®).
AOK Baden-Württemberg framework agreement		 Novo Nordisk Pharma GmbH
1 bid received		 €216,000

Contracts won

DateContractBuyerAmount
19/10/2026 Cbam 578/2025 novo nordisk/01 SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA €2,884,615
15/10/2026 Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de SOMATROPINA PARA EL SÍNDROME DE NOONAN, para GESTIÓ PIUS HOSPITAL DE VALLS, SAM Gestió Pius Hospital de Valls, SAM €311,850
15/10/2026 Expediente 2204/2025, nº siglo 578/2025, cca +6.i+e9q8j contr bam 2026 203195, con la empresa novo nordisk pharma, s.a Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar €20,894
29/09/2026 Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zu dem Wirkstoff Concizumab (Alhemo®) AOK Baden-Württemberg €216,000
29/09/2026 Vereinbarung gemäß § 130c Abs. 1 SGB V über die Gewährung von Rabatten für patentgeschützte Arzneimittel mit den Wirkstoffen Turoctocog alfa (NovoEight®) und Turoctocog alfa pegol (Esperoct®). AOK Baden-Württemberg €216,000
25/09/2026 Suministro de concizumab (DOE) OSAKIDETZA - Servicio Vasco de Salud - Organización Central €1,720,926
18/09/2026 Suministro del medicamento exclusivo: Eptacog alfa (NOVOSEVEN). Servicio Madrileño de Salud - Hospital Universitario La Paz €1,498,940
18/09/2026 Contr 2026 200982 cbam-1 granada amc 2204-2025 (578/2025) medicamentos exclusivos Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves €270,317
03/09/2026 Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Esperoct (B02BD02), NovoEight (B02BD02) und Alhemo (B02BX10) zur Behandlung der Hämophilie AOK Sachsen - Anhalt €1
22/07/2026 Huelva 1º cbam am 2204/2025 (nº siglo 578/2025 ;cca:+6.i+e9q8j) Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez €791,847
20/07/2026 Suministro de medicamentos con principio activo Factor VIII de la coagulacion recombinante. Servicio Murciano de Salud - Junta de Compras €9,441,858
shared by 5
13/07/2026 Acuerdo marco del suministro de somatropina para el síndrome de noonan Consorci de Salut i d'Atenció Social de Catalunya €1,097,250

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.